About us
Mölnlycke at a glance
A world-leading MedTech company
Mölnlycke has been at the forefront of change since 1849, pioneering radical innovation that improves the quality of life for patients and those who care for them, while reducing the environmental impact of healthcare. We provide effective solutions and we’re always on the lookout for new ways to improve. Focusing on wound care and surgical procedures, Mölnlycke is organised around four Business Areas: Wound care, Operating room solutions, Gloves and Antiseptics.
-
Our purpose
Our purpose is to revolutionise care for people and planet. We drive change that improves the health and wellbeing of patients and those who care for them – while reducing the environmental footprint of healthcare.
Read more about our purpose -
Our strategy
Mölnlycke aims to become the market leader across all segments and geographies where the company operates. This ambition is firmly grounded in a strong portfolio of brands, as well as strong heritage of customer-insight driven innovations that improve the lives of people and planet.
Read more about our strategy
A strategic priority
We care about sustainability
Sustainability is a strategic priority at Mölnlycke and WeCare is our sustainability roadmap for 2030. It means creating shared value for all our stakeholders. It is a driver for growth, innovation and productivity and an essential part of our employee value proposition.
How we work with sustainabilityLatest news
-
Mölnlycke Health Care publishes Annual report for 2024
Gothenburg, Sweden. 1 April 2025. Today Mölnlycke Health Care has published its Annual report for 2024, including the sustainability report.
-
New study demonstrates the potential benefits of dressing regime improvements in delivering value-based chronic wound care
-
Mölnlycke Health Care expands investment in Tamer Mölnlycke Care joint venture
Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% to 60% to become majority shareholder in Tamer Mölnlycke Care - a joint venture with Tamer Group, the market leader in healthcare distribution in the Kingdom of Saudi Arabia.
-
Mölnlycke Health Care agrees to acquire leading wound cleansing manufacturer to consolidate its position as global leader in wound care
Mölnlycke signed an agreement to acquire P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound cleansing and moisturizing.
-
Mölnlycke signs a EUR 350 million revolving credit facility
On 28 April 2023, Mölnlycke entered into a new EUR 350 million multicurrency revolving credit facility. The facility has a tenor of five years with two one-year extension options and will be used as a backup for general corporate purposes. The facility is a refinancing of the existing and undrawn revolving credit facility signed in 2017.
-
Mölnlycke Health Care announces launch of the 2025 Future Summit
Mölnlycke Health Care’s Wound Care business area is delighted to announce the launch of its 2025 Future Summit, an educational event bringing together healthcare professionals (HCPs) from across Europe, the Middle East, and Africa (EMEA).
-
Mölnlycke Health Care wins Swedish Sustainability Tech award
Mölnlycke is proud to announce that it has been awarded the Capgemini Swedish Sustainability Tech Award 2024 for Mölnlycke ProcedurePak® trays. This accolade recognises the company’s innovative practices and dedication to revolutionise healthcare for people and planet.
-
Mölnlycke Health Care appoints Guillaume Joucla as Chief Financial Officer
Joucla’s extensive experience and insights to drive financial strategy and growth initiatives.
-
Mölnlycke® Health Care and Transdiagen announce research collaboration to drive innovation in wound care